EQS Group-Ad-hoc: HBM Healthcare Investments AG / Key word(s): Monthly Figures
HBM Healthcare Investments AG
Bundesplatz 1
CH-6300 Zug - Switzerland
Tel. +41 41 710 75 77
Fax +41 41 710 75 78
E-Mail: hbm@hbmhealthcare.com
Wenn Sie keine Mitteilungen von HBM Healthcare Investments mehr wünschen, können Sie diese hier abbestellen.
Should you wish to unsubscribe from all HBM Healthcare Investments news, please unsubscribe here.
Disclaimer:
This message may contain confidential or privileged Information and is intended only for the use of the addressee named above. If you are not the intended recipient of this message, you are hereby notified that you must not use, copy, disclose or take any action based on this message or information herein. If you have received this message by error, please advise the sender immediately and delete this message. The publication is for information purposes only and does not constitute an offer to sell or a solicitation to buy or subscribe for securities. Past performance is not a reliable indicator or guarantee of future results, prices of shares and the income from them may fall as well as rise and investors may not get back the amount originally invested. The investor must be aware of the investment risk and personal risk ability. Some information quoted was obtained from external sources HBM considers to be reliable. HBM cannot guarantee the adequacy, accuracy, timeliness or completeness of or be held responsible or liable for errors of fact regarding such data and information obtained from third parties, and this data may change with market conditions. If the email looks unformatted, please use this alternative link.
End of ad hoc announcement |
Language: | English |
Company: | HBM Healthcare Investments AG |
Bundesplatz 1 | |
6300 Zug | |
Switzerland | |
Phone: | +41438887171 |
Fax: | +41438887172 |
E-mail: | info@hbmhealthcare.com |
Internet: | https://www.hbmhealthcare.com |
ISIN: | CH0012627250 |
Valor: | 1262725 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1203310 |
End of Announcement | EQS Group News Service |
|
1203310 01-Jun-2021 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.